Furthermore, the AV-1451 tracer measures Alzheimer’s disease-type mixed 3R/4R tau deposits and not isolated 3R or 4R tau aggregates, and the specificity and sensitivity of AV-1451 to Alzheimer’s disease-related tauopathy are not perfect. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.